| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 1e-05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |